Menu
Enrolling by invitation NCT06726304

Increasing Physical Contact Between Prenatally Anxious/Depressed Mothers and Their Infants to Improve Maternal Sensitivity.

No phase Interventional Prenatal Anxiety Prenatal Depression Maternal Sensitivity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Baby Carrier Intervention.
Who it may be relevant to
Registry conditions: Prenatal Anxiety, Prenatal Depression, Maternal Sensitivity. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Pilot Intervention Study To Increase Physical Contact Between Prenatally Anxious/Depressed Mothers And Their Infants To Improve Maternal Sensitivity

Overview

The goal of this randomized controlled pilot trial is to evaluate the feasibility, acceptability, and clinical utility of a baby carrier intervention aimed at improving maternal sensitivity and mother-infant bonding in prenatally anxious/depressed mothers. The study has three main questions: 1. Is the intervention feasible (e.g., enrollment and recruitment rates) and acceptable to participants (e.g., compliance and perceived benefits)? 2. Does the intervention improve maternal sensitivity compared to a waitlist control group? 3. Does the intervention increase mother-infant neural synchrony compared to a waitlist control group, measured using functional near-infrared spectroscopy? Participants will A. Choose between two soft ergonomic baby carriers and be expected to use the baby carrier for the prescribed amount of time (intervention group). B. Have two home visits, one at the start (at postpartum week 8) and another one at the end of the study (at postpartum week 16). C. Complete questionnaires about depression and anxiety symptoms, mother-infant bonding, and rate protocol burden. D. Share their feelings and lived experiences about the frequent use of a baby carrier and increased physical contact with their baby through open-ended interview questions (intervention group).

Detailed description

The intervention involves mothers in the experimental group using a soft ergonomic baby carrier for a prescribed amount of time over a period of six weeks. Weekly adherence self-reports will be collected via REDCap. Participants will be recruited from the Perinatal Multisite Databank (PMD), an ongoing clinical cohort of individuals receiving psychiatric services during pregnancy and the first six months postpartum in the province of Quebec, Canada.

Interventions

  • Behavioral Baby Carrier Intervention
    Mothers in the intervention group will have the opportunity to choose between two different soft ergonomic baby carriers and will receive instructions on how to use the carrier of their choice. Infants will be placed chest-to-chest in the carrier, supported by the mother's upper torso for a prescribed amount of time during the period of six weeks.

Primary outcome measures

  • Feasibility: Proportion of Eligible Participants Successfully Enrolled and Retained Over 12 Months [Time frame: From the beginning of recruitment to the end of the last assessment (at 16 weeks postpartum)]
Secondary outcome measures (1)
  • Acceptability: Adherence to the baby carrier intervention [Time frame: From the beginning of the intervention (at 8 weeks postpartum) to the end of the intervention (up until 16 weeks postpartum)]

Eligibility criteria

Inclusion criteria

  • 18 years or older
  • be able to communicate in English or French
  • diagnosed with a depressive or anxiety disorder (or both) during their intake visit within the Perinatal Multisite Databank (PMD)
  • residing in the greater Montreal area
  • have given birth to a healthy baby

Exclusion criteria

  • having known alcohol or substance use issues,
  • having been diagnosed with psychosis or schizophrenia during the PMD intake assessment, or have had thoughts of harming the self or the baby
  • having physical restrictions that may prevent the regular use of a baby carrier
  • taking any medications regularly that cause potential participants to feel drowsy or dizzy
  • already using a baby carrier with their current baby for more than 5 hours a week

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Quadruple blind
Primary purpose
Other

Study locations

Canada · 1 center
  • Lady Davis Institute of the Jewish General Hospital — Montreal

Identifiers

NCT: NCT06726304 · 2024-989

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗